Domov › Prekomerna telesna teža › Texas › Dallas
Klinične študije za Prekomerna telesna teža v Dallas, TX
20 študij za Prekomerna telesna teža išče udeležence na lokacijah v Dallas in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.
Uradno besedilo študije (angleško)
Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →
Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
Vključevanje udeležencevFaza 2
- Velocity Clinical Research - Dallas /ID# 282734, Dallas
AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight
Vključevanje udeležencevFaza 3
- UT Southwestern Med Center, Dallas
AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight
Vključevanje udeležencevFaza 3
- North Texas Endocrine Center, Dallas
A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide
Vključevanje udeležencevFaza 3
- UT Southwestern Med Center, Dallas
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
Vključevanje udeležencevFaza 3
- Cedar Health Research - Texas Native Health, Dallas
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
Vključevanje udeležencevFaza 3
- Velocity Clinical Research, Dallas, Dallas
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
Vključevanje udeležencevFaza 3
- UT Southwestern Medical Center, Dallas
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Vključevanje udeležencevFaza 3
- Thyroid Endocrinology and Diabetes, Dallas
- Soltero Cardiovascular Research Center, Dallas
- Zenos Clinical Research, Dallas
- in še 2
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
Vključevanje udeležencevFaza 3
- Velocity Clinical Research, Dallas, Dallas
- UT Southwestern Medical Center, Dallas
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
Vključevanje udeležencevFaza 2
- FutureSearch Trials of Dallas, Dallas
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
Vključevanje udeležencevFaza 3
- Velocity Clinical Research, Dallas
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
Vključevanje udeležencevFaza 3
- University of Texas Southwestern Medical Center - Children's Medical Center Dallas, Dallas
Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight
Vključevanje udeležencevFaza 3
- Cedar Health Research, Dallas
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
Vključevanje udeležencevFaza 2
- Velocity Clinical Research, Dallas, Dallas
- FutureSearch Trials of Dallas, Dallas
A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes
Vključevanje udeležencevFaza 2
- Mercy Family Clinic, Dallas
- Velocity Clinical Research, Dallas, Dallas
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
Vključevanje udeležencevFaza 4
- Modern Research Associates, PLLC, Dallas
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
Vključevanje udeležencevFaza 3
- Cedar Health Research, LLC, Dallas
AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain
Vključevanje udeležencevFaza 3
- Mercy Family Clinic, Dallas
Comparing Outcomes Among Children With Obesity in a Community Healthy Lifestyle Program
Vključevanje udeležencev
- University of Texas Southwestern, Children's Health, Dallas
Healthy Living BEYOND Weight Study
Vključevanje udeležencevOpazovalna študija
- American Heart Association, Dallas
Študije za Prekomerna telesna teža v drugih mestih
- San Antonio, TX34 študij
- Houston, TX33 študij
- Chicago, IL28 študij
- Orlando, FL27 študij
- Las Vegas, NV23 študij
- Miami, FL23 študij
- Atlanta, GA20 študij
- New York City, NY19 študij
- Jacksonville, FL19 študij
- Washington, DC19 študij
- Austin, TX18 študij
- Baltimore, MD17 študij
Druge študije v Dallas
- Rak dojke55 študij
- Nemalicelični pljučni rak52 študij
- Metastatski rak42 študij
- Srčno popuščanje42 študij
- Rak (vse vrste)37 študij
- Rak prostate36 študij
- Kolorektalni rak33 študij
- Debelost30 študij
- Rak jajčnikov28 študij
- Rak mehurja27 študij
- Rak pljuč27 študij
- Rak endometrija24 študij
Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.